We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

209 hedge funds and large institutions have $5.18B invested in Arcellx in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 58 increasing their positions, 81 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

29% more capital invested

Capital invested by funds: $4.01B → $5.18B (+$1.16B)

3% more funds holding

Funds holding: 202209 (+7)

2.32% more ownership

Funds ownership: 111.39%113.72% (+2.3%)

8% less funds holding in top 10

Funds holding in top 10: 1211 (-1)

22% less call options, than puts

Call options by funds: $7.49M | Put options by funds: $9.65M

28% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 81

Holders
209
Holders Change
+7
Holders Change %
+3.47%
% of All Funds
2.74%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.14%
New
31
Increased
58
Reduced
81
Closed
22
Calls
$7.49M
Puts
$9.65M
Net Calls
-$2.16M
Net Calls Change
+$37.6M
Name Holding Trade Value Shares
Change
Change in
Stake
GS
1
Gilead Sciences
California
$552M
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$522M +$317M +4,408,630 +227%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$473M -$15.2M -210,834 -4%
PBA
4
Paradigm Biocapital Advisors
New York
$382M
Vanguard Group
5
Vanguard Group
Pennsylvania
$321M -$2.72M -37,798 -1%
BlackRock
6
BlackRock
New York
$278M -$5.78M -80,288 -2%
NMC
7
NEA Management Company
Maryland
$250M -$50.4M -700,000 -19%
RCM
8
RA Capital Management
Massachusetts
$249M
PA
9
Perceptive Advisors
New York
$203M -$694K -9,647 -0.4%
SOCM
10
SR One Capital Management
Pennsylvania
$193M
State Street
11
State Street
Massachusetts
$125M -$4.77M -66,286 -4%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$104M -$12.6M -174,722 -12%
VPC
13
Vestal Point Capital
New York
$103M -$108M -1,500,000 -55%
AIIC
14
AJU IB Investment Company
South Korea
$86M
Citadel Advisors
15
Citadel Advisors
Florida
$83.9M +$59.3M +823,090 +415%
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
$83.2M -$696K -9,661 -0.9%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$76.1M -$2.55M -35,474 -4%
JP Morgan Chase
18
JP Morgan Chase
New York
$72.5M -$6.8M -94,465 -10%
Capital World Investors
19
Capital World Investors
California
$64.3M
CAM
20
Cormorant Asset Management
Massachusetts
$63.6M -$1.8M -25,000 -3%
BAMCO Inc
21
BAMCO Inc
New York
$45.2M +$2.32M +32,227 +6%
SSA
22
Schonfeld Strategic Advisors
New York
$41.1M +$11.1M +153,587 +44%
AAA
23
Affinity Asset Advisors
New York
$41M +$360K +5,000 +1%
Goldman Sachs
24
Goldman Sachs
New York
$36.8M -$4.48M -62,164 -12%
Morgan Stanley
25
Morgan Stanley
New York
$35.5M -$6.09M -84,631 -16%

ACLX Hedge Fund Activity: Q3 2025 in Review

209 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q3 2025, worth a combined $5.18B — up 29% from $4.01B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ACLX positions and 22 closed out — a net gain of 9 holders — while 58 added to existing stakes and 81 trimmed.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $317M. The largest seller was Vestal Point Capital, cutting an estimated $108M.

  • 209 institutional investors held Arcellx (ACLX) as of Q3 2025, up from 202 in Q2 2025.
  • Funds reported $5.18B of Arcellx stock for Q3 2025, up 29% quarter-over-quarter.
  • 31 funds opened new Arcellx positions in Q3 2025 and 22 closed out, a net change of +9 holders.
  • The largest Arcellx buyer in Q3 2025 was T. Rowe Price Investment Management, an estimated $317M added.
  • The largest Arcellx seller in Q3 2025 was Vestal Point Capital, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2025.